GGrantIndex
← Leaderboards

Temple Univ Of The Commonwealth

Philadelphia, PA

Compare ↔
$1,337,176,874
Total funding
1,226
Grants

Funding over time

peak $96.5M · FY2006–25
$100M$75M$50M$25M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,327,646,840 · 1209
CDC$5,711,132 · 8
ACF$2,346,134 · 3
AHRQ$1,324,222 · 4
FDA$148,546 · 1
SAMHSA$0 · 1

By mechanism

R01$832,341,967 · 499
P01$86,928,623 · 81
R21$62,879,472 · 161
U01$47,391,728 · 20
P30$45,930,531 · 45
UM1$24,038,480 · 1

Investigators at Temple Univ Of The Commonwealth

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Concepcion Estaras$2,130,6282 gr2Julia Kobulsky$1,502,7252 gr3Christopher Keith Thompson$1,460,5351 gr4Xiaolei Liu$1,401,5061 gr5Lauren E Bradley$985,4191 gr6Ajit Magadum$770,9581 gr7Jillian Noelle Simon$717,5581 gr8Daniel Kwanwoo Kim$668,0411 gr

Emerging Leaders

6–10 yrs in

1Brandie Depaoli Taylor$5,025,7314 gr2Heather M Murphy$3,961,5272 gr3Vincent Voelz$3,094,4551 gr4Shivayogi V Hiremath$2,783,4502 gr5Tania Giovannetti$2,670,4123 gr6Ross Wang$2,591,1072 gr7Suresh K Verma$2,436,3922 gr8Sumant Puri$2,108,6462 gr

All-Time

Most funded here, all years

1Yuri Persidsky$24,741,82213 gr2Tomasz Skorski$21,974,89214 gr3Domenico Pratico$19,087,94313 gr4Sudhir Kumar$16,724,8429 gr5Xiao-Feng Yang$15,763,9018 gr6Raj Kishore$15,248,3238 gr7Michael Edgar Selzer$13,783,8417 gr8Richard T Pomerantz$12,889,61514 gr

Largest grants

Research Facility for Temple Institute for Translational Neuroscience$11,851,780
C06 · FY2010 · RR
CRISPR for Cure$4,807,696
UM1 · FY2021 · AI
CRISPR for Cure$4,807,696
UM1 · FY2022 · AI
CRISPR for Cure$4,807,696
UM1 · FY2023 · AI
CRISPR for Cure$4,807,696
UM1 · FY2025 · AI
CRISPR for Cure$4,807,696
UM1 · FY2024 · AI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2021 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2023 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2020 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2022 · HL
Exosomes as mediators of cardiac injury and repair$2,393,843
P01 · FY2024 · HL
Exosomes as mediators of cardiac injury and repair$2,379,218
P01 · FY2025 · HL
Exosomes as mediators of cardiac injury and repair$2,363,250
P01 · FY2017 · HL
Exosomes as mediators of cardiac injury and repair$2,362,544
P01 · FY2018 · HL
Exosomes as mediators of cardiac injury and repair$2,325,872
P01 · FY2019 · HL
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2018 · HL
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2017 · HL
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2016 · HL
Novel Mechanisms of Cardiac Injury and Repair$2,312,979
P01 · FY2014 · HL
Improving Cardiac Function After Myocardial Infarction$2,305,267
P01 · FY2012 · HL